Codexis (CDXS) Assets Average (2011 - 2026)
Codexis' (CDXS) quarterly Assets Average came in at $138.6 million in Q1 2026, little changed year-on-year from $138.9 million in Q1 2025, and up 1.99% quarter-over-quarter from $135.9 million in Q4 2025.
Codexis (CDXS) Assets Average (2011 - 2026) Analysis & Trends
Codexis' Assets Average history runs 16 years deep, the most recent figure standing at $138.6 million for Q1 2026.
- On a quarterly basis, Assets Average changed 0.26% year-over-year to $138.6 million in Q1 2026; TTM through Mar 2026 was $138.6 million, a 0.26% change from a year earlier, with the FY2025 full-year figure at $148.4 million, up 3.93% from the prior year.
- Assets Average improved to $138.6 million in Q1 2026 per CDXS's latest filing, from $135.9 million in the prior quarter.
- Across five years, Assets Average topped out at $242.8 million in Q4 2022 and bottomed at $131.1 million in Q3 2025.
- The 5-year median for Assets Average is $145.5 million (2023), against an average of $175.1 million.
- Across the five-year window, Assets Average gained 11.03% in 2022 and slumped 40.08% in 2023, its largest moves.
- Year by year, Assets Average stood at $242.8 million in 2022, then slumped by 40.08% to $145.5 million in 2023, then rose by 2.12% to $148.6 million in 2024, then dropped by 8.56% to $135.9 million in 2025, then rose by 1.99% to $138.6 million in 2026.
- Per Business Quant, the three latest CDXS Assets Average figures stand at $138.6 million (Q1 2026), $135.9 million (Q4 2025), and $131.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.30 Bn |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn | 138.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138.58 Mn |
| Dec 31, 2025 | 135.88 Mn |
| Sep 30, 2025 | 131.10 Mn |
| Jun 30, 2025 | 133.57 Mn |
| Mar 31, 2025 | 138.95 Mn |
| Dec 31, 2024 | 148.60 Mn |
| Sep 30, 2024 | 140.09 Mn |
| Jun 30, 2024 | 140.78 Mn |
| Mar 31, 2024 | 143.06 Mn |
| Dec 31, 2023 | 145.51 Mn |
| Sep 30, 2023 | 180.61 Mn |
| Jun 30, 2023 | 212.41 Mn |
| Mar 31, 2023 | 234.23 Mn |
| Dec 31, 2022 | 242.84 Mn |
| Sep 30, 2022 | 235.13 Mn |
| Jun 30, 2022 | 235.12 Mn |
| Mar 31, 2022 | 240.83 Mn |
| Dec 31, 2021 | 236.97 Mn |
| Sep 30, 2021 | 219.93 Mn |
| Jun 30, 2021 | 212.24 Mn |